Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
R-(-)-gossypol acetic acid
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Study of Lenalidomide in Combination With AT-101 for Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
RPCI I 101307
, NCT01003769
2.
Phase II Study of R-(-)-Gossypol (AT-101) and Androgen Ablation Therapy in Patients With Newly Diagnosed Metastatic Prostate Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CINJ-080707
, 080707, 8014, CINJ-0220080008, NCT00666666
3.
Phase II Study of R-(-)-Gossypol Acetic Acid in Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-8035
, MC0771, 8035, NCT00848016
4.
Phase I Study of R-(-)-Gossypol, Cisplatin, and Etoposide in Patients With Advanced, Refractory Solid Tumors or Extensive Stage Small Cell Lung Cancer
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
WCCC-CO-07901
, 8062, CO 07901, NCT00544596
5.
Phase I Study of R-(-)-Gossypol Acetic Acid in Combination With Paclitaxel and Carboplatin in Patients With Metastatic or Unresectable Solid Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CINJ-050905
, 050905, 8016, 0220090064, NCT00891072
6.
Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer
Phase:
Phase I
Type:
Treatment
Status:
Approved-not yet active
Age:
19 and over
Sponsor:
Other
Protocol IDs:
F090218006
, UAB 0831, NCT00934076
Select All on Page
Help with Results
